Clinical Trial Update: A Study to Learn More About How Well Aficamten Works in Japanese Participants With Symptomatic Obstructive Hypertrophic Cardiomyopathy [Phase 3]

View source ↗

Summary

Phase 3 study update evaluating how well aficamten works in Japanese participants with obstructive hypertrophic cardiomyopathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obstructive Hypertrophic Cardiomyopathy

Drugs mentioned

• Aficamten (aficamten)

Snippet

Sponsor: Bayer | Conditions: Obstructive Hypertrophic Cardiomyopathy | Phase 3 | Status: ACTIVE_NOT_RECRUITING